DNASENSE ApS: Financial statements 2022
CVR: 36036869
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
DNASENSE ApS (CVR 36036869) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 4,258,224 and a net result of DKK 866,938 compared with DKK 77,939 the year before. That is an increase of 40.1% compared with the year before. Equity in the 2022 report amounted to DKK 851,968. The solvency ratio was 30%. The company had 6 employees in the financial year.
- Gross Profit
- DKK 4,258,224
- Profit/Loss
- DKK 866,938
- Equity
- DKK 851,968
- Total Assets
- DKK 2,835,715
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 4.3 mio. | 867 t. | 852 t. | 6 |
| 2021 | - | 3 mio. | 78 t. | -15 t. | 5 |
| 2020 | - | 1.4 mio. | -1.1 mio. | -93 t. | 5 |
| 2019 | - | 3.4 mio. | 679 t. | 1.3 mio. | 4 |
| 2018 | - | 2.3 mio. | 524 t. | 910 t. | 2 |
Official annual report
Keep an eye on DNASENSE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
DNASENSE ApS has published its annual report for 2021. Gross profit came to DKK 3,039,679, and the net result was DKK 77,939.
About DNASENSE ApS
DNASENSE ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Mads Toft Søndergaard. The board consists of Anders Christian Neto de Sousa Grøn (chair), Anders Mohr Christensen, Henrik Bjørn Nielsen and Manoj Nirmal Dadlani. The company is owned by Clinical-Microbiomics A/S. The company has 15 employees (2018). In 2025, the company reported a gross profit of DKK 7,915,337 and a net result of DKK 894,729. Equity in the 2025 report amounted to DKK 1,639,012.